Articles

The CEO of Novo Nordisk is set to face pointed questions on Capitol Hill Tuesday about the prices of the Danish pharmaceutical giant’s blockbuster drugs Ozempic and Wegovy.

“While it has not been my baseline outlook, I cannot rule out the risks that progress on inflation could continue to stall,” Fed Gov. Michelle Bowman said.

TikTok Music failed to renegotiate its contract with Universal Music Group following a prolonged clash between the two companies

Levi Strauss & Co.’s goal of generating $9 billion to $10 billion in annual revenue by 2027 will be pushed back as the denim-clothing company is still seeing pressure on its customer after a long inflationary period, new Chief Executive Michelle Gass told the Financial Times.

Even this top-performing pension plan has found it hard to beat low-fee passive investments.

Walmart’s stock was headed back into record territory on Tuesday, as Truist turned bullish on the discount retailer amid accelerating market-share gains.

Pete Stavros, a high-ranking executive at private-equity firm KKR & Co. Inc. known for rewarding staff with stock, on Tuesday launched an organization aimed at promoting employee stock ownership programs, or ESOPs.

Oil futures rose Tuesday morning, lifted after China announced a range of stimulus measures aimed at boosting the economy of the world’s largest crude importer.

AutoZone’s stock dropped in early Tuesday trading, after the auto-parts retailer reported quarterly earnings and sales that rose, but not enough to meet expectations, as U.S. results continued to underperform.

Snowflake outlined plans to raise $2 billion in debt to finance a $575 million share buyback plan and a series of possible acquisitions and strategic investments

Energy company insiders are purchasing far more shares than they’re selling. Here’s what they’re buying.

Biogen Inc.’s stock rose 2% early Tuesday, after the company and Belgian partner UCB announced positive results in a late-stage trial